Exploration of Diazaspiro Cores as Piperazine Bioisosteres in the Development of σ2 Receptor Ligands.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
27 Jul 2022
Historique:
received: 27 06 2022
revised: 19 07 2022
accepted: 21 07 2022
entrez: 28 7 2022
pubmed: 29 7 2022
medline: 30 7 2022
Statut: epublish

Résumé

A series of σ2R compounds containing benzimidazolone and diazacycloalkane cores was synthesized and evaluated in radioligand binding assays. Replacing the piperazine moiety in a lead compound with diazaspiroalkanes and the fused octahydropyrrolo[3,4-b] pyrrole ring system resulted in a loss in affinity for the σ2R. On the other hand, the bridged 2,5-diazabicyclo[2.2.1]heptane, 1,4-diazepine, and a 3-aminoazetidine analog possessed nanomolar affinities for the σ2R. Computational chemistry studies were also conducted with the recently published crystal structure of the σ2R/TMEM97 and revealed that hydrogen bond interactions with ASP29 and π-stacking interactions with TYR150 were largely responsible for the high binding affinity of small molecules to this protein.

Identifiants

pubmed: 35897835
pii: ijms23158259
doi: 10.3390/ijms23158259
pmc: PMC9332756
pii:
doi:

Substances chimiques

Ligands 0
Receptors, sigma 0
Piperazine 1RTM4PAL0V

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIA NIH HHS
ID : R41 AG052249
Pays : United States
Organisme : NIA NIH HHS
ID : R42 AG052249
Pays : United States
Organisme : NIA NIH HHS
ID : R42AG052249
Pays : United States

Références

J Alcohol Drug Depend. 2016;4:
pubmed: 27376101
Mol Neurobiol. 2020 Sep;57(9):3803-3813
pubmed: 32572762
Tetrahedron Lett. 2017 Feb 1;58(5):466-469
pubmed: 31762498
J Comput Chem. 2008 Aug;29(11):1859-65
pubmed: 18351591
Eur J Med Chem. 2011 Oct;46(10):5154-61
pubmed: 21899931
ACS Chem Neurosci. 2017 Aug 16;8(8):1801-1811
pubmed: 28644012
Nature. 2016 Apr 28;532(7600):527-30
pubmed: 27042935
J Med Chem. 2013 Sep 26;56(18):7137-60
pubmed: 23734634
J Phys Chem B. 2010 Jun 17;114(23):7830-43
pubmed: 20496934
Eur J Med Chem. 2019 Mar 1;165:250-257
pubmed: 30685525
J Comput Chem. 2017 Jun 5;38(21):1879-1886
pubmed: 28497616
J Med Chem. 2022 Apr 28;65(8):6261-6272
pubmed: 35404616
J Med Chem. 1995 May 26;38(11):1998-2008
pubmed: 7783131
Front Pharmacol. 2020 Dec 07;11:589810
pubmed: 33364961
Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W368-71
pubmed: 15980491
Nat Commun. 2011 Jul 05;2:380
pubmed: 21730960
Front Pharmacol. 2019 Jun 14;10:687
pubmed: 31258483
J Med Chem. 2017 Dec 14;60(23):9905-9910
pubmed: 29125762
PLoS One. 2014 Nov 12;9(11):e111899
pubmed: 25390692
Trends Pharmacol Sci. 2010 Dec;31(12):557-66
pubmed: 20869780
Sci Rep. 2018 Nov 15;8(1):16845
pubmed: 30443021
J Comput Chem. 2009 Dec;30(16):2785-91
pubmed: 19399780
Org Lett. 2016 Oct 21;18(20):5272-5275
pubmed: 27736075
Bioorg Med Chem. 2006 Oct 15;14(20):6988-97
pubmed: 16837201
J Med Chem. 2019 May 23;62(10):5132-5147
pubmed: 31021617
Bioorg Med Chem Lett. 2004 Jan 5;14(1):195-202
pubmed: 14684327
J Chem Theory Comput. 2016 Jan 12;12(1):405-13
pubmed: 26631602
J Med Chem. 1995 May 26;38(11):2009-17
pubmed: 7783132
Nature. 2021 Dec;600(7890):759-764
pubmed: 34880501
Eur J Pharmacol. 2015 Jul 5;758:16-23
pubmed: 25843410
Biophys J. 2014 Jul 1;107(1):134-45
pubmed: 24988348
Eur J Pharmacol. 1994 Jun 15;268(1):9-18
pubmed: 7925616
J Mol Graph Model. 2011 Apr;29(6):888-93
pubmed: 21310640
J Cheminform. 2011 Oct 07;3:33
pubmed: 21982300
eNeuro. 2020 Nov 4;7(6):
pubmed: 33028631
J Med Chem. 2011 Feb 24;54(4):1022-32
pubmed: 21229979
Nucleic Acids Res. 2012 Jan;40(Database issue):D370-6
pubmed: 21890895
Nucleic Acids Res. 2012 Jul;40(Web Server issue):W537-41
pubmed: 22570416
Cent Nerv Syst Agents Med Chem. 2009 Sep;9(3):205-19
pubmed: 20021355
EBioMedicine. 2015 Oct 19;2(11):1806-13
pubmed: 26870805
Cancer Res. 1995 Jan 15;55(2):408-13
pubmed: 7812973
Front Mol Neurosci. 2018 Feb 12;11:17
pubmed: 29483862
J Med Chem. 2018 Jun 28;61(12):5367-5379
pubmed: 29856625
Proteins. 2006 Jun 1;63(4):928-38
pubmed: 16493626
J Neurosci Res. 2021 Apr;99(4):1161-1176
pubmed: 33480104
Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):8072-7
pubmed: 8755605
Proc Natl Acad Sci U S A. 2017 Jul 3;114(27):7160-7165
pubmed: 28559337
Pharm Acta Helv. 2000 Mar;74(2-3):211-8
pubmed: 10812960

Auteurs

Kuiying Xu (K)

Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

Chia-Ju Hsieh (CJ)

Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

Ji Youn Lee (JY)

Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

Aladdin Riad (A)

Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

Nicholas J Izzo (NJ)

Cognition Therapeutics Inc., Pittsburgh, PA 15203, USA.

Gary Look (G)

Cognition Therapeutics Inc., Pittsburgh, PA 15203, USA.

Susan Catalano (S)

Cognition Therapeutics Inc., Pittsburgh, PA 15203, USA.

Robert H Mach (RH)

Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

Articles similaires

Receptor, Cannabinoid, CB1 Ligands Molecular Dynamics Simulation Protein Binding Thermodynamics
Proteins Protein Binding Ligands Internet Databases, Protein

Expanding the antiprotozoal activity and the mechanism of action of n-butyl and iso-butyl ester of quinoxaline-1,4-di-

Alonzo González-González, Oscar Sánchez-Sánchez, Lilián Yépez-Mulia et al.
1.00
Giardia lamblia Trichomonas vaginalis Entamoeba histolytica Antiprotozoal Agents Quinoxalines

Orientation-dependent CD45 inhibition with viral and engineered ligands.

Marta T Borowska, Liu D Liu, Nathanael A Caveney et al.
1.00
Leukocyte Common Antigens Humans Ligands T-Lymphocytes Viral Proteins

Classifications MeSH